endpoint Clinical, a provider of Interactive Response Technology (IRT) systems via phone (IVRS), web (IWRS) and mobile (IMRS) for global clinical trials, has launched its next-generation PULSE 3.0 platform. The enhanced PULSE platform provides highly customized configuration and deployment of complex trial designs in a rapid and repeatable manner.

Jonathan Dole, endpoint's CEO and co-founder, said, "With the introduction of PULSE 3.0, endpoint's users have access to a robust array of IRT trial design features and functionality through an intuitive interface."